|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net income (loss) for the year | ||||
| Fair value change of other liabilities | ||||
| Deferred tax expense | ||||
| Foreign exchange on cash | ||||
| Write-off of deferred royalty acquisitions | ||||
| Share-based compensation | ||||
| Impairment charges | ||||
| Impairment recovery | ||||
| Interest and finance charges | ||||
| Amortization | ||||
| Depletion on royalties and depreciation-like charges | ||||
| Realized loss on investments | ||||
| Revaluation of streams and other interests | ||||
| Cash Flows From Used In Operating Activities Gross | ||||
| Accounts receivable | ||||
| Prepaid expenses | ||||
| Accounts payable and accrued liabilities | ||||
| Income taxes payable | ||||
| Net cash flows from operating activities | ||||
| Cash flows used in investing activities | ||||
| Acquisition of royalties | ||||
| Pre-acquisition royalty revenues | ||||
| Acquisition of streams and other interests - financial assets | ||||
| Restricted cash | ||||
| Deferred royalty acquisitions | ||||
| Proceeds from sale of investments | ||||
| Net cash flows used in investing activities | ||||
| Share issuance | ||||
| Share issue costs | ||||
| Credit facility drawdowns | ||||
| Credit facility repayments | ||||
| Transaction costs related to credit facility | ||||
| Payments of interest on credit facility | ||||
| Dividends paid | ||||
| Share redemption (normal course issuer bid) | ||||
| Exercise of warrants | ||||
| Net cash flows from (used in) financing activities | ||||
| Decrease in cash | ||||
| Impact of foreign exchange on cash | ||||
| Cash, beginning of the year | ||||
| Cash, end of the year | ||||
Loading...
